TY - JOUR
T1 - The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments
AU - Salter, Amber
AU - Fox, Robert J.
AU - Tyry, Tuula
AU - Cutter, Gary
AU - Marrie, Ruth Ann
N1 - Funding Information:
Robert J Fox receives personal consulting fees from Actelion, Biogen, EMD Serono, Genentech, Novartis, and Teva; has served on advisory committees for Actelion, Biogen, and Novartis, and receives clinical trial contract and research grant funding from Biogen and Novartis.Ruth Ann Marrie receives research funding from Canadian Institutes of Health Research, Research Manitoba, Multiple Sclerosis Society of Canada, Multiple Sclerosis Scientific Foundation, National Multiple Sclerosis Society, Rx & D Health Research Foundation, the Waugh Family Chair in Multiple Sclerosis, Crohn's and Colitis Canada. The study was not supported by a corporate sponsor, but we have indicated all sources of financial support. The corresponding author had full access to all the data in the study and final responsibility for the decision to submit for publication. NARCOMS is a project of the Consortium of Multiple Sclerosis Centers (CMSC). Fatigue Performance Scale, Copyright Registration Number/Date: TXu000743629/1996-04-04; assigned to DeltaQuest Foundation, Inc. effective October 1, 2005. US copyright law governs terms of use.
Funding Information:
Ruth Ann Marrie receives research funding from Canadian Institutes of Health Research , Research Manitoba , Multiple Sclerosis Society of Canada , Multiple Sclerosis Scientific Foundation , National Multiple Sclerosis Society , Rx & D Health Research Foundation, the Waugh Family Chair in Multiple Sclerosis, Crohn's and Colitis Canada.
Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2019/6
Y1 - 2019/6
N2 - Introduction: Fatigue is an important aspect of health-related quality of life and a commonly reported symptom by many persons with multiple sclerosis (MS). There are multiple validated instruments available to assess fatigue in MS with differing benefits for each instrument. Objective: We aimed to assess the relationship between the PROMIS Fatigue instrument and the Fatigue Performance Scale (FPS) in the NARCOMS registry. Additionally, we aimed to examine the association of fatigue with social participation. Methods: The NARCOMS registry is a voluntary, self-report registry, which has enrolled participants with MS who provide semi-annual updates regarding their MS. The Fall 2016 semi-annual survey included the PROMIS Fatigue and Ability to Participate in Social Roles and Activities questionnaires, in addition to demographic and clinical information. We examined the association between instruments using Spearman correlations. Linear and ordinal regression models were used to evaluate associations with fatigue using the PROMIS Fatigue and the FPS. Results: Of the 7,006 Fall 2016 respondents, 6,883 (98.2%) completed the PROMIS instruments. Respondents were mostly female (79.5%) and Caucasian (87.4%), had a mean (SD) age of 59.9 (10.2) years and moderate disability level (median Patient Determined Disease Steps [PDDS] 4 [early cane]). The mean (SD) PROMIS Fatigue T-score was 56.8 (11.0) and median (25th, 75th) FPS was 3 [moderate] (1 [minimal], 4 [severe]). Fatigue measures were strongly correlated (r = 0.83, 95% CI: [0.827, 0.842]). Factors consistently associated with fatigue were PDDS level, depression and pain functionality scales, and symptoms worsening. The ability to participate in social roles and activities was strongly associated with fatigue and had an independent effect on fatigue after adjusting for PDDS, depression and pain levels. Conclusion: A high proportion of respondents experience some level of fatigue and it is independently associated with reduced social participation.
AB - Introduction: Fatigue is an important aspect of health-related quality of life and a commonly reported symptom by many persons with multiple sclerosis (MS). There are multiple validated instruments available to assess fatigue in MS with differing benefits for each instrument. Objective: We aimed to assess the relationship between the PROMIS Fatigue instrument and the Fatigue Performance Scale (FPS) in the NARCOMS registry. Additionally, we aimed to examine the association of fatigue with social participation. Methods: The NARCOMS registry is a voluntary, self-report registry, which has enrolled participants with MS who provide semi-annual updates regarding their MS. The Fall 2016 semi-annual survey included the PROMIS Fatigue and Ability to Participate in Social Roles and Activities questionnaires, in addition to demographic and clinical information. We examined the association between instruments using Spearman correlations. Linear and ordinal regression models were used to evaluate associations with fatigue using the PROMIS Fatigue and the FPS. Results: Of the 7,006 Fall 2016 respondents, 6,883 (98.2%) completed the PROMIS instruments. Respondents were mostly female (79.5%) and Caucasian (87.4%), had a mean (SD) age of 59.9 (10.2) years and moderate disability level (median Patient Determined Disease Steps [PDDS] 4 [early cane]). The mean (SD) PROMIS Fatigue T-score was 56.8 (11.0) and median (25th, 75th) FPS was 3 [moderate] (1 [minimal], 4 [severe]). Fatigue measures were strongly correlated (r = 0.83, 95% CI: [0.827, 0.842]). Factors consistently associated with fatigue were PDDS level, depression and pain functionality scales, and symptoms worsening. The ability to participate in social roles and activities was strongly associated with fatigue and had an independent effect on fatigue after adjusting for PDDS, depression and pain levels. Conclusion: A high proportion of respondents experience some level of fatigue and it is independently associated with reduced social participation.
KW - Fatigue
KW - Multiple sclerosis
KW - PROMIS
KW - Patient reported outcomes
KW - Social participation
UR - http://www.scopus.com/inward/record.url?scp=85065092701&partnerID=8YFLogxK
U2 - 10.1016/j.msard.2019.04.014
DO - 10.1016/j.msard.2019.04.014
M3 - Article
C2 - 31063935
AN - SCOPUS:85065092701
SN - 2211-0348
VL - 31
SP - 165
EP - 172
JO - Multiple Sclerosis and Related Disorders
JF - Multiple Sclerosis and Related Disorders
ER -